102 related articles for article (PubMed ID: 2551767)
1. High plasma pancreastatinlike immunoreactivity in a patient with malignant insulinoma.
Tateishi K; Funakoshi A; Jimi A; Funakoshi S; Tamamura H; Yajima H; Matsuoka Y
Gastroenterology; 1989 Nov; 97(5):1313-8. PubMed ID: 2551767
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a tumor-derived human protein related to chromogranin A and its in vitro conversion to human pancreastatin-48.
Tamamura H; Ohta M; Yoshizawa K; Ono Y; Funakoshi A; Miyasaka K; Tateishi K; Jimi A; Yajima H; Fujii N
Eur J Biochem; 1990 Jul; 191(1):33-9. PubMed ID: 2165909
[TBL] [Abstract][Full Text] [Related]
3. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues.
Schmidt WE; Siegel EG; Lamberts R; Gallwitz B; Creutzfeldt W
Endocrinology; 1988 Sep; 123(3):1395-404. PubMed ID: 3042370
[TBL] [Abstract][Full Text] [Related]
4. Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma.
Sekiya K; Ghatei MA; Minamino N; Bretherton-Watt D; Matsuo H; Bloom SR
FEBS Lett; 1988 Feb; 228(1):153-6. PubMed ID: 2830133
[TBL] [Abstract][Full Text] [Related]
5. Pancreastatin producing cell line from human pancreatic islet cell tumor.
Funakoshi A; Tateishi K; Tsuru M; Jimi A; Wakasugi H; Ikeda Y; Kono A
Biochem Biophys Res Commun; 1990 Apr; 168(2):741-6. PubMed ID: 2159299
[TBL] [Abstract][Full Text] [Related]
6. Pancreastatin-like immunoreactivity in human carcinoid disease.
McGrath-Linden SJ; Johnston CF; O'Connor DT; Shaw C; Buchanan KD
Regul Pept; 1991 Mar; 33(1):55-70. PubMed ID: 2047545
[TBL] [Abstract][Full Text] [Related]
7. Plasma pancreastatin-like immunoreactivity in various diseases.
Tateishi K; Funakoshi A; Wakasugi H; Iguchi H; Shinozaki H; Abe M; Funakoshi S; Tamamura H; Yajima H; Matsuoka Y
J Clin Endocrinol Metab; 1989 Dec; 69(6):1305-8. PubMed ID: 2555388
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a tumor-derived human pancreastatin-related protein.
Funakoshi S; Tamamura H; Ohta M; Yoshizawa K; Funakoshi A; Miyasaka K; Tateishi K; Tatemoto K; Nakano I; Yajima H
Biochem Biophys Res Commun; 1989 Oct; 164(1):141-8. PubMed ID: 2803289
[TBL] [Abstract][Full Text] [Related]
9. Pancreastatin distribution and plasma levels in the pig.
Bretherton-Watt D; Ghatei MA; Bishop AE; Facer P; Fahey M; Hedges M; Williams G; Valentino KL; Tatemoto K; Roth K
Peptides; 1988; 9(5):1005-14. PubMed ID: 3244555
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A(210-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors.
Woussen-Colle MC; Lingier P; Vertongen P; Vandermeers-Piret MC; Vandermeers A; Robberecht P
Peptides; 1994; 15(5):869-74. PubMed ID: 7984507
[TBL] [Abstract][Full Text] [Related]
11. Pancreastatin molecular forms in normal human plasma.
Kitayama N; Tateishi K; Funakoshi A; Miyasaka K; Shimazoe T; Kono A; Iwamoto N; Matsuoka Y
Life Sci; 1994; 54(21):1571-8. PubMed ID: 8196476
[TBL] [Abstract][Full Text] [Related]
12. The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system.
Bishop AE; Bretherton-Watt D; Hamid QA; Fahey M; Shepherd N; Valentino K; Tatemoto K; Ghatei MA; Bloom SR; Polak JM
Mol Cell Probes; 1988 Sep; 2(3):225-35. PubMed ID: 2851738
[TBL] [Abstract][Full Text] [Related]
13. The extraction and purification of a peptide from rat insulinoma tissue.
al-Ahkras G; Hampton SM; Wright J; Marks V
Biochim Biophys Acta; 1989 Dec; 993(2-3):275-9. PubMed ID: 2557091
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes in immunoreactive content of novel pituitary protein 7B2 in human pancreas and its identification in pancreatic tumors.
Suzuki H; Christofides ND; Chretien M; Seidah NG; Polak JM; Bloom SR
Diabetes; 1987 Nov; 36(11):1276-9. PubMed ID: 2822517
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia.
Cohen RM; Given BD; Licinio-Paixao J; Provow SA; Rue PA; Frank BH; Root MA; Polonsky KS; Tager HS; Rubenstein AH
Metabolism; 1986 Dec; 35(12):1137-46. PubMed ID: 3023795
[TBL] [Abstract][Full Text] [Related]
16. Biochemical differences between human malignant and benign insulinoma tissues.
Nakazawa I; Ohneda A; Mura K
Tohoku J Exp Med; 1977 Mar; 121(3):275-80. PubMed ID: 193215
[TBL] [Abstract][Full Text] [Related]
17. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
Kohnert KD; Kändler C; Woltanski KP; Ziegler M
Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
Patel YC; Ganda OP; Benoit R
J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
[TBL] [Abstract][Full Text] [Related]
19. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
20. Secretion of pancreastatins from isolated, perfused, porcine adrenal glands.
Jensen TD; Fahrenkrug J; Holst JJ
Peptides; 1994; 15(3):519-27. PubMed ID: 7937328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
